Hangzhou Biotest Biotech (688767.SH): Net profit for the year 2024 was 177 million yuan, a year-on-year increase of 65.74%.

26/02/2025

GMT Eight

Hangzhou Biotest Biotech (688767.SH) released its 2024 annual performance report, reporting a total operating income of 561 million yuan during the reporting period, a year-on-year increase of 26.80%; net profit attributable to the owners of the parent company was 177 million yuan, a year-on-year increase of 65.74%; net profit attributable to the owners of the parent company after deducting non-recurring gains and losses was 127 million yuan, a year-on-year increase of 59.35%; basic earnings per share were 1.68 yuan/share.

Shandong Yisheng Livestock & Poultry Breeding (002458.SZ) net profit for the year 2024 was 512 million yuan, a decrease of 5.35% year-on-year.

Chengdu Jiachi Electronic Technology (688708.SH) had a net profit of 519 million yuan in 2024, a decrease of 7.99% compared to the previous year.

Contact: contact@gmteight.com

Hangzhou Biotest Biotech (688767.SH): Net profit for the year 2024 was 177 million yuan, a year-on-year increase of 65.74%.

RECOMMEND

HK Stock Market Move | Photovoltaic stocks fell further in the afternoon, with the internal competition within the photovoltaic industry still unresolved. This year, the domestic photovoltaic installed capacity may decline.

Citigroup: Maintain "Buy" rating on SHK PPT (00016) and raise target price to HK$88.8

HK Stock Market Move | UCD(01599) fell nearly 9% in the afternoon, with an estimated year-on-year decrease in net profit of about 39% to 49% last year.